A nice relevant study to our own 2017 paper https://t.co/29wM6Nj9Il Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk https://t.co/rc55PyElpU
ADAM metalloproteinases provide a new hope for treating glioblastoma. https://t.co/AMP35VWdeb https://t.co/KmkTwTMEr0
Brain cancer - glioblastoma: new possibility to reduce tumour cell spread in this aggressive malignancy. https://t.co/kqNH7Fgs2p
Therapies that block enzymes ADAM10 and ADAM17 may result in arresting Glioblastoma growth/ spreading. #BTSM https://t.co/uCKbbJI8Fz
Brain cancer: new way to reduce tumour cell spread in aggressive glioblastoma https://t.co/jQI7T8Trmd
MetalloprotADAM10/ADAM17 Mediate Migration&Diff:Glioblastoma Sphere-Forming Cells MolNeurobiol#springerlink https://t.co/FXCvHz16Fb
#oa: Metalloproteinases ADAM10 & ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells https://t.co/igTvQYFqyv
Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells https://t.co/Tkp1WRXJy2